-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GwlALbiAcOD3N5GvjVAnC8p1fSOHz4idNcBFoEhN5x/7H+NFlct4cpHBGUuzZLbk C63NvwlEyXbGvPq7b+c3fA== 0000874015-06-000026.txt : 20060306 0000874015-06-000026.hdr.sgml : 20060306 20060306212829 ACCESSION NUMBER: 0000874015-06-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060303 FILED AS OF DATE: 20060306 DATE AS OF CHANGE: 20060306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN RICHARD K CENTRAL INDEX KEY: 0001181549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 06668609 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-03-03 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001181549 BROWN RICHARD K C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Vice President Common Stock 2006-03-03 2006-03-03 4 M 0 1008 6.84 A 3356 D Common Stock 2006-03-03 2006-03-03 4 S 0 1000 8.20 D 2356 D Common Stock 2006-03-03 2006-03-03 4 S 0 8 8.26 D 2348 D Employee Stock Option (right to buy) 6.84 2006-03-03 2006-03-03 4 M 0 1008 0 D 2004-01-02 2006-05-24 Common Stock 1008 4770 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2-16-06. Stock option under the Isis Pharmaceuticals, Inc. 2000 Broad-Based Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 1-2-04. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,125 shares per year. The option was exercisable as to 5,778 shares on 3-3-06 prior to the reported exercise. /s/B. Lynne Parshall 2006-03-06 -----END PRIVACY-ENHANCED MESSAGE-----